nf-core/crisprseq: a versatile pipeline for comprehensive analysis of CRISPR gene editing and screening assays
In recent years, CRISPR technology has become widely applied in scientific research, being simpler, cheaper, and more precise than previous gene-editing techniques. This editing technology can be used for various applications, such as gene knockout, gene knock-in, CRISPR activation (CRISPRa), CRISPR interference (CRISPRi), CRISPR screens, base editing, and prime editing. The share of pipelines to analyze the variety of CRISPR editing methods is low, and until now, none of them caters to both gene editing and CRISPR-based functional genomics. Here, we introduce nf-core/crisprseq, a Nextflow DSL2 pipeline for the assessment of CRISPR gene editing and screening assays. The workflow is written in a modularized fashion to allow the easy incorporation of new steps. nf-core/crisprseq is the first generic pipeline enabling the analysis of the broad spectrum of CRISPR designs. We show the performance and usability of the software using publicly available datasets.
Authors
- Júlia Mir-Pedrol (ORCID: https://orcid.org/0000-0001-6104-9260)
- Marc Güell (ORCID: https://orcid.org/0000-0003-4000-7912)
- Laurence Kuhlburger
- Sabrina Krakau (ORCID: https://orcid.org/0000-0003-0603-7907)
- Matteo Bonfanti (ORCID: https://orcid.org/0000-0002-6361-5163)
- Metin Yazar (ORCID: https://orcid.org/0000-0002-2657-3072)
- Marta Sanvicente-García (ORCID: https://orcid.org/0000-0002-4508-2834)
- Gisela Gabernet
- nf-core community
- Colm J Ryan
Institutions
- University College Dublin (IE)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Universitat Pompeu Fabra (ES)
- Human Technopole (IT)
- Centre for Genomic Regulation (ES)
- Hertie Institute for Clinical Brain Research (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- NAR Genomics and Bioinformatics
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1093/nargab/lqaf214
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- St. Jude Children's Research Hospital
- Higher Education Authority
- Deutsche Forschungsgemeinschaft
- Eberhard Karls Universität Tübingen